Here are four key points:
1. Safe Orthopaedics’ products have received marketing approval for the Chilean market.
2. Mexico is currently reviewing the company’s application for marketing approval, which Safe Orthopaedics expects to receive by the fourth quarter of 2016.
3. Safe Orthopaedics received regulatory approval for its SteriSpine ranges in Australia and New Zealand earlier this year.
4. The France-based medical technology company develops and markets a range of sterile implants and associated single-use surgical instruments.
More articles on devices:
The efficacy of electrical bone stimulators & ultrasound for bone healing — Dr. Mohit Bhandari weighs in with new evidence
Global orthopedic trauma devices market to reach $9.4B by 2020: 4 things to know
Bristol Hospital 1st in Connecticut to offer Rotator Cuff Bioinductive Implant — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
